LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
ABCL AbCellera Biologics
- 2.990
- -0.040-1.32%
Close Dec 27 16:00 ET
- 2.931
- -0.059-1.98%
Post 19:02 ET
883.15MMarket Cap-4.90P/E (TTM)
3.060High2.870Low3.38MVolume3.010Open3.030Pre Close9.97MTurnover1.78%Turnover RatioLossP/E (Static)295.37MShares6.05552wk High0.82P/B569.24MFloat Cap2.33552wk Low--Dividend TTM190.38MShs Float71.910Historical High--Div YieldTTM6.27%Amplitude2.335Historical Low2.947Avg Price1Lot Size
AbCellera Biologics Key Stats
EPS
According to the latest financial report of AbCellera Biologics, the latest earnings per share (TTM) for the company is -0.17. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about AbCellera Biologics's free cash flow? The latest report shows it as -47.40M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of AbCellera Biologics shows that the company's current ratio is 9.34, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of AbCellera Biologics, the quick ratio is 8.88, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of AbCellera Biologics? The latest ROE figure is -4.67%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of AbCellera Biologics, the total asset return on investment (ROA) is -3.64%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check AbCellera Biologics's latest financial report to see how their gross margin is doing - currently at 92.79%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of AbCellera Biologics, the net profit margin is -785.42%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...